fda approval semaglutide mash Novo Nordisk's Wegovy gets accelerated US for liver disease Semaglutide (Wegovy) for MASH 🔗

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system

Bretz F, Xun X

These results were attributed not just to improved glycemic control, but to anti-inflammatory effects on arterial walls, reduced plaque formation, and enhanced endothelial function

The primary endpoint and all key secondary endpoints of the study were successfully achieved in 2024

Individual Metabolic Biomarkers and Treatment Suitability High cholesterol encompasses various metabolic patternssome patients have elevated LDL, others elevated triglycerides, and some display metabolic dysfunction affecting lipid clearance

The Case for Intramuscular BPC 157 Injections The argument for IM injections is almost entirely built on one concept: localization